Vericel (VCEL) EBT Margin (2011 - 2026)

Vericel's (VCEL) quarterly EBT Margin came in at 9.31% in Q1 2026, up 1215.0% year-on-year from 0.71% in Q1 2025, and down 135.85% quarter-over-quarter from 25.98% in Q4 2025.

Vericel (VCEL) EBT Margin (2011 - 2026) Analysis & Trends

Vericel has disclosed EBT Margin across 16 years of filings, most recently posting 9.31% for Q1 2026.

  • EBT Margin for Q1 2026 came in at 9.31%, up 1215.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.65% (up 635.0% YoY), and the FY2025 annual result was 6.29%, up 186.0% from the prior year.
  • EBT Margin came in at 9.31% for Q1 2026 at Vericel, down from 25.98% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.47% in Q4 2024 to a low of 24.19% in Q2 2022.
  • The 5-year median for EBT Margin is 8.66% (2023), against an average of 3.18%.
  • Across the five-year window, EBT Margin slumped 1480 bps in 2022 and surged 1327 bps in 2023, its largest moves.
  • Vericel's EBT Margin stood at 12.57% in 2022, then surged by 73 bps to 21.68% in 2023, then rose by 22 bps to 26.47% in 2024, then slipped by 2 bps to 25.98% in 2025, then tumbled by 136 bps to 9.31% in 2026.
  • The last three EBT Margin figures came in at 9.31% (Q1 2026), 25.98% (Q4 2025), and 7.56% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn -9.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.31%
Dec 31, 2025 25.98%
Sep 30, 2025 7.56%
Jun 30, 2025 -0.84%
Mar 31, 2025 -21.46%
Dec 31, 2024 26.47%
Sep 30, 2024 -1.56%
Jun 30, 2024 -8.88%
Mar 31, 2024 -7.52%
Dec 31, 2023 21.68%
Sep 30, 2023 -8.66%
Jun 30, 2023 -10.92%
Mar 31, 2023 -18.24%
Dec 31, 2022 12.57%
Sep 30, 2022 -17.01%
Jun 30, 2022 -24.19%
Mar 31, 2022 -19.78%
Dec 31, 2021 8.84%
Sep 30, 2021 -14.29%
Jun 30, 2021 -9.40%